Abstract P4-12-25: Randomized phase II study of pre-operative docetaxel, carboplatin with trastuzumab (TCH) and/or/lapatinib (L) in HER-2 positive (H+) breast cancer patients (BC pts). ICORG 10-05

Mapping Intimacies ◽

10.1158/0008-5472.sabcs13-p4-12-25 ◽

2013 ◽

Cited By ~ 4

Author(s):

J Crown ◽

L Coate ◽

M Keane ◽

J Kennedy ◽

S O'Reilly ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Randomized Phase Ii ◽

Her 2

Download Full-text

Phase II Study of HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada471552 ◽

2007 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Phase II Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada533841 ◽

2010 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study

Annals of Oncology ◽

10.1093/annonc/mds132 ◽

2012 ◽

Vol 23 (12) ◽

pp. 3069-3074 ◽

Cited By ~ 94

Author(s):

E. Alba ◽

L. Calvo ◽

J. Albanell ◽

J.R. De la Haba ◽

A. Arcusa Lanza ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Neoadjuvant Treatment ◽

Luminal Breast Cancer ◽

Breast Cancer Patients ◽

Randomized Phase Ii

Download Full-text

P5-19-02: Comparison of the Incidence of Peripheral Neuropathy with Eribulin Mesylate Versus Ixabepilone in Metastatic Breast Cancer Patients: A Randomized Phase II Study.

10.1158/0008-5472.sabcs11-p5-19-02 ◽

2011 ◽

Cited By ~ 1

Author(s):

L Vahdat ◽

P Gopalakrishna ◽

AA Garcia ◽

C Vogel ◽

C Pellegrino ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Peripheral Neuropathy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

Randomized Phase Ii

Download Full-text

PRELIMINARY RESULTS ON THE IMPACT OF HYPOFRACTIONATED RADIOTHERAPY IN CARDIAC TOXICITY (CARDIAC FUNCTION) IN EARLY STAGED LEFT SIDED BREAST CANCER PATIENTS: A PROSPECTIVE RANDOMIZED PHASE II STUDY

Radiotherapy and Oncology ◽

10.1016/s0167-8140(11)71807-2 ◽

2011 ◽

Vol 98 ◽

pp. S41 ◽

Cited By ~ 1

Author(s):

I. Fragkandrea-Nixon ◽

V. Kouloulias ◽

N. Mpaziotis ◽

S. Mpetsou ◽

A. Sotiropoulou-Lontou ◽

...

Keyword(s):

Breast Cancer ◽

Cardiac Function ◽

Cancer Patients ◽

Phase Ii ◽

Cardiac Toxicity ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Preliminary Results ◽

Randomized Phase Ii ◽

The Impact

Download Full-text

Phase II Study of HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada456015 ◽

2006 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Phase II Study of a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine Administered to Stage IIIB and IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab Monotherapy

10.21236/ada486630 ◽

2008 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iiib ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Trastuzumab Monotherapy ◽

Positive Breast Cancer

Download Full-text

Abstract P3-14-21: Phase II Study of Single Agent Trifunctional Antibody Ertumaxomab (Anti-HER-2 & Anti-CD3) in HER-2 Low Expressing Hormone-Refractory Advanced Breast Cancer Patients (ABC)

10.1158/0008-5472.sabcs10-p3-14-21 ◽

2010 ◽

Cited By ~ 4

Author(s):

F Cardoso ◽

L Dirix ◽

PF Conte ◽

V Semiglazov ◽

S de Placido ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2 ◽

Hormone Refractory

Download Full-text

Abstract OT3-04-04: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease, with immunologic and genomic correlative studies

10.1158/1538-7445.sabcs18-ot3-04-04 ◽

2019 ◽

Author(s):

N Vidula ◽

A Goga ◽

J Hwang ◽

MC Liu ◽

BH Park ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Chest Wall ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Randomized Phase Ii ◽

Correlative Studies

Download Full-text

Abstract OT1-02-03: TBCRC 044: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease

10.1158/1538-7445.sabcs17-ot1-02-03 ◽

2018 ◽

Author(s):

N Vidula ◽

A Goga ◽

M Krummel ◽

J Hwang ◽

M Liu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Chest Wall ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Randomized Phase Ii

Download Full-text